Anteo Diagnostics Ltd has released a press release.
AnteoTech and Axxin Build Successful Sepsis Multiplex Test
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- R & D Refund Received
- Rights Issue Raises $2.15 million
- Heads of Agreement signed with Merck
- Rights Commence Trading
- Rights Issue Prospectus
Later from AnteoTech
- AnteoTech Advances Battery Technology Program
- AnteoTech Developing Multiplex Test for COVID-19
- AnteoTech Secures $3.76M Option Underwriting Agreement
- Preliminary Final Report
- AnteoTech COVID-19 Antigen Test Progress Update
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech